Scientists at the University of Alberta have helped with advanced research to detect Alzheimer's disease by using saliva samples by Edmonton Journal.
"All projections are increasing Alzheimer's disease and associated dementia, and costs are enormous," said Roger Dixon, professor of psychology at Alberdi University.
The number of people with Canadian dementia is increasing, and it costs USD10.6 million every year to help them care, according to the Canadian Alzheimer's Association.
Dixon collaborated with chemistry professor Liang Li before dealing with a serious problem before beginning to develop symptoms of Alzheimer's disease. "Our goal was to identify signs already inside the proven things," said Dixon.
"Today we do not know which treatment or management it is best to totally delay Alzheimer's disease," Li said.
Li and Dixon analyzed 109 patients with saliva samples that could cause Alzheimer's disease, whether or not they are cognitive illnesses.
Li's most advanced technological tools and Dixon offered high-quality saliva samples for many years.
The use of advanced technology has been the key. "We could not even build a large network three years ago," said Li. The mass spectrometer was used to identify and measure more than 6,000 metabolites because they are chemical compounds in the body.
Li and Dixon were identified as biomarkers in three of these compounds: if something happens in the body, the signal may go wrong. It might be possible to identify different stages of Alzheimer's in the same way that blood glucose or blood sugar is diagnosed and treated.
Read the whole story in the Edmonton Journal.